arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

ARROWHEAD PHARMACEUTICALS, INC.

ARWR
$66.98 ▼ -4.84 (-6.74%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
84 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
56
Health
Fair
Neutral
auto_awesome

Analytical Summary

ARROWHEAD PHARMACEUTICALS, INC. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $9.6B
Dividend Yield
Revenue Growth 171.0%
Op. Margin -226.0%
ROIC -36.5%
FCF / Share $-1.26
Trailing P/E
Price / Book 20.3x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

84-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$75.25M
↑ +171.0%
Net Income Profit after all expenses
$-194.28M
↓ -10.9%
Operating Margin Operating profit as % of sales
-226.0%
↓ -18.0% 61th
FCF / Share Free cash flow per share
$-1.26
↓ -320.0%

Health Breakdown

Profitability
57
Returns
43
Financial Health
100
Cash Quality
0

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 23 years · 84 quarters